Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burnaby
SEC filing record 1 source field available
Fiscal year end
31 December
Xenon Pharmaceuticals Inc. has filed 789 SEC EDGAR filings since 16 Aug 2013

SEC filing history

Showing 751-775 of 789 matching filings.

Per page
25
Current page
31
S-8 File 333-199860

S-8

Filing date
05 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-198666

424B4

Filing date
05 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-198666

EFFECT filing

Filing date
04 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
04 Nov 2014
Reporting date
04 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Nov 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CERTNAS File 001-36687

AUTO-GENERATED PAPER DOCUMENT

Filing date
16 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-36687

8-A12B

Filing date
10 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-198666

AMENDMENT NO. 2 TO FORM S-1

Filing date
09 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .